|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Invitro activity of piperacillin-tazobactam against isolates from patients enrolled in climcal trials显示文摘 | Jacobus NV Spengler MD etal | 1996 | Int J Antimicrob Agents1996，7，： | 1 |
| 2 | Comparative in vitro activities of daptomycin and vancomycin against resistant Gram-positive pathogens显示文摘 | Snydman DR Jacobus NV McDermott LA | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 3 | Comparative in vitro activities of daptomycin and vancomycin against resistant grampositive pathogens 显示文摘 | Jacobus NV McDermott LA | 2000 | Artimicrob Agents Chemother2000，44，： | 1 |
| 4 | Comparative in vitro activities of daptomycin and vancommycin against resistant gram-positive pathogens显示文摘 | Snydman DR Jacobus NV McDermott | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 5 | Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens显示文摘 | Snydman DR Jacobus NV McDermott LA | 2000 | Antimicrob Agents Chemother2000，44，12： | 1 |
| 6 | Evaluation of the in vitro activity of NVP PDF-713 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group 显示文摘 | SNYDMAN DR JACOBUS NV MCDERMOTT LA | 2005 | J Antimicrob Chemother2005，55，6： | 1 |
| 7 | Activity of a novel cyclic lipopeptide,CB-183,315,against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens 显示文摘 | Snydman DR Jacobus NV McDermott LA | 2012 | Antimicrob Agents Chemother2012，56，6： | 1 |
| 8 | Determina- tion of absolute configuration of natural products: theoretical calculation of electronic circular dichroism as a tool 显示文摘 | Snydman DR Jacobus NV McDermott LA | 2010 | Clin Infect Dis2010，14，16： | 1 |
| 9 | In vitro and in vivo antibacterial activities of the glycycclines, a new class of semisynthetic tetracycline显示文摘 | Testa RT Petersen PJ Jacobus NV | 1993 | Antimicrob Agent Chemother1993，37，11： | 1 |
| 10 | Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Sreptococcus pneumoniae to the glycylcyclines显示文摘 | Weiss WJ Jacobus NV Petersen PJ | 1995 | J Antimicrob Chemother1995，36，1： | 1 |
| 11 | National survey on the susceptibility of bacteroides fragilis group:report nd analysis of trends in the united states from, 1997 to 2004 显示文摘 | Snydman DR Jacobus NV Mcdermott A Et al | 2007 | Antimicrob Agents Chemother2007，51，5： | 1 |
| 12 | In vitro activites of aminomethyI-substituted analogs of noveI tetrahydrofuranyl cabapenems 显示文摘 | WEISS WJ PETERSEN PJ JACOBUS NV | 1999 | Antimirob Agents Chemother1999，43，3： | 1 |
| 13 | In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-Butylglycylamido derivative of minocycline (GAR-936)显示文摘 | Petersen PJ Jacobus NV Weiss WJ | 1999 | Antimicrob Agents Chemother1999，43，4： | 1 |
| 14 | Comparative in vitro activities of daptomycin and vancommycin against resistant gram-positive pathogens显示文摘 | Snydman DR Jacobus NV McDermott LA | 2000 | Antimicrob Agents Chemother2000，44，12： | 1 |
| 15 | Effect of broadspectrum pa- renteral antibiotics on composition of intestinal microflora of hunmns 显示文摘 | Giuliano M Barza M Jacobus NV | 1987 | Antimicrob Agents Chemother1987，31，2： | 1 |
| 16 | National survey on the susceptibility of Bacteroides fragilis group: re- port and analysis of trends in the United States from 1997 to 2004显示文摘 | Snydman DR Jacobus NV McDermott LA | 2007 | Antimicrob Agents Chemother2007，51，5： | 1 |
| 17 | National survey on the susceptibility of Bacteroidesfragilis group: report and analysis of trends in the United States from 1997 to 2004显示文摘 | Snydman DR Jacobus NV McDermott LA | 2007 | Antimicrobial Agents and Chemotherapy2007，51，5： | 1 |
| 18 | In vitro and in vivo activities of LJC10,627,a new carbapenem with stability to dehydropeptidase I显示文摘 | Petersen PJ Jacobus NV Weiss WJ | 1991 | Antimicrob Agents Chemother1991，35，1： | 1 |
| 19 | In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-tbutylglycylamido derivative of minocycline (GAR-936) 显示文摘 | Petersen PJ Jacobus NV Weiss WJ | 1999 | Antimicrob Agents Chemother1999，43，4： | 1 |
| 20 | TEM- 28 from an Escherichia coli clinical isolate is a member of the His -164 family of TEM-1 extended - spectrum β-lactamases 显示文摘 | Bradford PA Jacobus NV Bhachech N | 1996 | Amt imicrob Agents Chemother1996，40，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员